Evidence map›Paper›PMID 38029259›Full record

ArticleFrontiers in cellular and infection microbiology2023

Skin microbiome profile in people living with HIV/AIDS in Cameroon.

Kazuhiro Ogai, Benderli Christine Nana, Yukie Michelle Lloyd, John Paul Arios, Boonyanudh Jiyarom, Honore Awanakam, Livo Forgu Esemu, Aki Hori, Ayaka Matsuoka, Firzan Nainu and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Alterations of the skin microbiome in HIV infection with pruritus.Frontiers in cellular and infection microbiology · 2026
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Kazuhiro OgaiAI Hospital/Macro Signal Dynamics Research and Development Center (ai@ku), Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Benderli Christine NanaBiotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Yukie Michelle LloydDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, United States.
John Paul AriosDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, United States.
Boonyanudh JiyaromDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, United States.
Honore AwanakamBiotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Livo Forgu EsemuBiotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Aki HoriFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Ayaka MatsuokaFaculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Firzan NainuFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Rosette MegnekouBiotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Rose Gana Fomban LekeBiotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Gabriel Loni EkaliBiotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Shigefumi OkamotoFaculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Takayuki KuraishiFaculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Université de Yaoundé I · CMKanazawa University · JPUniversity of Hawaiʻi at Mānoa · USHasanuddin University · IDIshikawa Prefectural Nursing University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of pathogens and the state of diseases, particularly skin diseases, may alter the composition of human skin microbiome. HIV infection has been reported to impair gut microbiome that leads to severe consequences. However, with cutaneous manifestations, that can be life-threatening, due to the opportunistic pathogens, little is known whether HIV infection might influence the skin microbiome and affect the skin homeostasis. This study catalogued the profile of skin microbiome of healthy Cameroonians, at three different skin sites, and compared them to the HIV-infected individuals. Taking advantage on the use of molecular assay coupled with next-generation sequencing, this study revealed that alpha-diversity of the skin microbiome was higher and beta-diversity was altered significantly in the HIV-infected Cameroonians than in the healthy ones. The relative abundance of skin microbes such as

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsMicrobiotaCameroonHumansSkinAIDSCameroonCutibacteriumHIVskin microbiome

Identifiers

PMID38029259
PMCPMC10644231
OpenAlexW4388080899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.